Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Operating Expenses: 2009-2024

Historic Operating Expenses for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to $73.1 million.

  • OptimizeRx's Operating Expenses fell 2972.87% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.8 million, marking a year-over-year decrease of 2238.85%. This contributed to the annual value of $73.1 million for FY2024, which is 545.73% up from last year.
  • As of FY2024, OptimizeRx's Operating Expenses stood at $73.1 million, which was up 545.73% from $69.3 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Operating Expenses registered a high of $73.1 million during FY2024, and its lowest value of $26.2 million during FY2020.
  • In the last 5 years, OptimizeRx's Operating Expenses had a median value of $51.3 million in 2022 and averaged $51.0 million.
  • As far as peak fluctuations go, OptimizeRx's Operating Expenses skyrocketed by 4529.97% in 2022, and later surged by 545.73% in 2024.
  • OptimizeRx's Operating Expenses (Annual) stood at $26.2 million in 2020, then surged by 34.44% to $35.3 million in 2021, then soared by 45.3% to $51.3 million in 2022, then soared by 35.2% to $69.3 million in 2023, then increased by 5.46% to $73.1 million in 2024.
  • Its Operating Expenses stands at $73.1 million for FY2024, versus $69.3 million for FY2023 and $51.3 million for FY2022.